iBio (IBIO) Inventory (2021 - 2022)
iBio's (IBIO) quarterly Inventory came in at $3.9 million in Q2 2022, up 14344.44% year-on-year from N/an in Q2 2021, and up 18.79% on a QoQ basis from $3.3 million in Q1 2022.
iBio (IBIO) Inventory (2021 - 2022) Analysis & Trends
iBio (IBIO) has 2 years of Inventory data on file, last reported at $3.9 million in Q2 2022.
- On a quarterly basis, Inventory rose 14344.44% year-over-year to $3.9 million in Q2 2022; TTM through Jun 2022 was $3.9 million, a 14344.44% increase from a year earlier, with the FY2022 full-year figure at $3.9 million, up 14344.44% from the prior year.
- Inventory for Q2 2022 stood at $3.9 million, up from $3.3 million in the prior quarter.
- Over the last five years, Inventory for IBIO reached as high as $3.9 million in Q2 2022 and fell as low as $27000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 681.59 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.77 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 3.10 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 371.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 3.90 Mn |
| Mar 31, 2022 | 3.28 Mn |
| Dec 31, 2021 | 1.99 Mn |
| Sep 30, 2021 | 587,000.00 |
| Jun 30, 2021 | 27,000.00 |